Ellen Lentz

593 total citations
18 papers, 475 citations indexed

About

Ellen Lentz is a scholar working on Hepatology, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Ellen Lentz has authored 18 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 9 papers in Epidemiology and 3 papers in Psychiatry and Mental health. Recurrent topics in Ellen Lentz's work include Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (5 papers). Ellen Lentz is often cited by papers focused on Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (5 papers). Ellen Lentz collaborates with scholars based in United States, Switzerland and Belgium. Ellen Lentz's co-authors include James D. Lincoln, James P. Toombs, Philip B. Vasseur, Ann L. Johnson, Jon G. Whitehair, Stephen R. Shifley, N. S. Wilkinson, Sugantha Govindarajan, Paul J. Pockros and L. R. McDowell and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Ellen Lentz

18 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Lentz United States 11 161 152 122 71 54 18 475
C. J. Green United Kingdom 9 19 0.1× 27 0.2× 123 1.0× 30 0.4× 6 0.1× 13 427
Karen J. Wolfsheimer United States 15 24 0.1× 4 0.0× 136 1.1× 34 0.5× 345 6.4× 20 697
Rosa Torres Spain 17 23 0.1× 3 0.0× 28 0.2× 96 1.4× 5 0.1× 37 737
Irene Cooper United Kingdom 19 11 0.1× 10 0.1× 15 0.1× 57 0.8× 7 0.1× 27 1.1k
M. Carole Thivierge Canada 15 55 0.3× 4 0.0× 57 0.5× 7 0.1× 3 0.1× 31 926
G. E. Thompson United Kingdom 18 36 0.2× 6 0.0× 80 0.7× 9 0.1× 11 0.2× 74 959
J. C. Caritez France 15 14 0.1× 32 0.2× 236 1.9× 20 0.3× 3 0.1× 32 724
J. PRUGNAUD France 14 22 0.1× 4 0.0× 48 0.4× 5 0.1× 9 0.2× 39 970
Zhifei Li China 14 166 1.0× 15 0.1× 13 0.1× 20 0.3× 1 0.0× 57 637
Claire Richardson United Kingdom 12 18 0.1× 4 0.0× 382 3.1× 20 0.3× 102 1.9× 19 705

Countries citing papers authored by Ellen Lentz

Since Specialization
Citations

This map shows the geographic impact of Ellen Lentz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Lentz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Lentz more than expected).

Fields of papers citing papers by Ellen Lentz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Lentz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Lentz. The network helps show where Ellen Lentz may publish in the future.

Co-authorship network of co-authors of Ellen Lentz

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Lentz. A scholar is included among the top collaborators of Ellen Lentz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Lentz. Ellen Lentz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Blanchard, Jack J., Henry A. Nasrallah, Philip D. Harvey, et al.. (2017). Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study. Schizophrenia Research. 185. 137–143. 29 indexed citations
2.
Nasrallah, Henry A., Philip D. Harvey, Daniel E. Casey, et al.. (2015). The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: A focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization. Schizophrenia Research. 166(1-3). 69–79. 19 indexed citations
3.
Umbricht, Daniel, et al.. (2012). P.3.a.013 A post-hoc analysis of the negative symptom factor score in a proof-of-concept study of glycine reuptake inhibitor bitopertin in schizophrenia. European Neuropsychopharmacology. 22. S311–S311. 3 indexed citations
4.
5.
Chung, Raymond T., Fred Poordad, Tarek Hassanein, et al.. (2010). Association of Host Pharmacodynamic Effects with Virologic Response to Pegylated Interferon alfa-2a/ Ribavirin in Chronic Hepatitis C. Hepatology. 52(6). 1906–1914. 8 indexed citations
6.
Balart, Luis A., et al.. (2010). Peginterferon α-2a Plus Ribavirin in Latino and Non-Latino Whites With HCV Genotype 1: Histologic Outcomes and Tolerability From the LATINO Study. The American Journal of Gastroenterology. 105(10). 2177–2185. 17 indexed citations
7.
Harrison, Stephen A., Fayez M. Hamzeh, Ellen Lentz, & John M. Vierling. (2010). 535 Virologic and Metabolic Responses in Chronic Hepatitis C (CHC) Patients With Insulin Resistance (IR) Treated With Pioglitazone and Peginterferon Alfa-2a Plus Ribavirin. Gastroenterology. 138(5). S–790. 1 indexed citations
8.
Pockros, Paul J., Fayez M. Hamzeh, Paul Martin, et al.. (2010). Histologic Outcomes in Hepatitis C–Infected Patients with Varying Degrees of Virologic Response to Interferon-Based Treatments. Hepatology. 52(4). 1193–1200. 38 indexed citations
9.
10.
Everson, Gregory T., Shoei‐Sheng Lee, Robert Reindollar, et al.. (2008). Histological benefits of virological response to peginterferon alfa‐2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis. Alimentary Pharmacology & Therapeutics. 27(7). 542–551. 48 indexed citations
11.
Khalili, Mandana, et al.. (2005). Pegylated Interferon α -2a With or Without Ribavirin in HCV/HIV Coinfection: Partially Blinded, Randomized Multicenter Trial. Digestive Diseases and Sciences. 50(6). 1148–1155. 8 indexed citations
12.
Herrine, Steven K., Robert S. Brown, David Bernstein, et al.. (2005). Peginterferon α-2a Combination Therapies in Chronic Hepatitis C Patients Who Relapsed After or Had a Viral Breakthrough on Therapy with Standard Interferon α-2b Plus Ribavirin: A Pilot Study of Efficacy and Safety. Digestive Diseases and Sciences. 50(4). 719–726. 25 indexed citations
13.
14.
Vasseur, Philip B., Ann L. Johnson, James D. Lincoln, et al.. (1995). Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. Journal of the American Veterinary Medical Association. 206(6). 807–811. 162 indexed citations
15.
McDowell, L. R., et al.. (1992). α-Tocopherol concentrations in serum and tissues of sheep fed different sources of vitamin E. Journal of Animal Science. 70(8). 2568–2573. 33 indexed citations
16.
Njeru, Carol, L. R. McDowell, N. S. Wilkinson, et al.. (1992). Serum α-tocopherol concentration in sheep after intramuscular injection of DL-α-tocopherol. Journal of Animal Science. 70(8). 2562–2567. 28 indexed citations
17.
Thurmon, J. C., et al.. (1991). Effect of midazolam preanesthetic administration on thiamylal induction requirement in dogs. American Journal of Veterinary Research. 52(5). 662–664. 10 indexed citations
18.
Shifley, Stephen R. & Ellen Lentz. (1985). Quick estimation of the three-parameter Weibull to describe tree size distributions. Forest Ecology and Management. 13(3-4). 195–203. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. J. Green Breakdown of academic impact, for papers by Karen J. Wolfsheimer Breakdown of academic impact, for papers by Rosa Torres Breakdown of academic impact, for papers by Irene Cooper Breakdown of academic impact, for papers by M. Carole Thivierge Breakdown of academic impact, for papers by G. E. Thompson Breakdown of academic impact, for papers by J. C. Caritez Breakdown of academic impact, for papers by J. PRUGNAUD Breakdown of academic impact, for papers by Zhifei Li Breakdown of academic impact, for papers by Claire Richardson
Rankless by CCL
2026